Cytokinetics Highlights Phase 3 Aficamten Data at ESC
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2026 Cytokinetics, Incorporated announced additional clinical data for aficamten from the ACACIA-HCM and...
HCM
Advertisement
Lexicon Pharmaceuticals Completes Enrollment in Phase 3 SONATA-HCM Trial
THE WOODLANDS, Texas, July 27, 2026 Lexicon Pharmaceuticals, Inc. announced the completion of patient enrollment and randomization in the...
Tenaya Reports Positive TN-201 Gene Therapy Data in MYBPC3-Associated HCM
SOUTH SAN FRANCISCO, Calif., June 3, 2026 Tenaya Therapeutics announced new interim data from its ongoing MyPEAK™-1 Phase 1b/2...
Tenaya Therapeutics Prepares New TN-201 Gene Therapy Data for Genetic Heart Disease
SOUTH SAN FRANCISCO, Calif., June 2, 2026 Tenaya Therapeutics announced that it will present new interim clinical data from...
Bristol Myers Camzyos Shows Strong Results in HCM Trial
PRINCETON, N.J., USA, March 29, 2026 Bristol Myers Squibb has announced positive Phase 3 results from the SCOUT-HCM trial...
Advertisement
